

Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice
Liz Andréa Villela Baroncini , Aguinaldo de Oliveira , Enrique Antonio Vidal , Graciliano José França , Paulo Sérgio Dalla Bona Stahlke , Alexandre Alessi and Dalton Bertolim Précoma.
Cardiovascular Ultrasound 2008, 6:52
“Forty-five percent of the patients were studied based on uncertain and inappropriate reasons.”
Appropriate studies were those for which patients had one or more risk factors; uncertain studies were those for which patients had nonspecific symptoms; and the studies for which patients had no risk factors or symptoms were considered to be inappropriate
The Mannhein Carotid IMT Consensus [3,5] and the ASE Consensus Statement [4] recommended IMT measurements for patients at intermediate CVD risk and in subjects with the following clinical circumstances: (1) family history of premature CVD in first-degree relatives; (2) individuals younger than 60 years old with severe abnormalities in a single risk factor who otherwise would not be candidates for pharmacotherapy; (3) women younger than 60 years of age with at least two CVD risk factors; and (4) in all epidemiological and interventional trials dealing with vascular diseases to better characterize the population investigated.
Descubra mais sobre EchoTalk Echocardiography
Assine para receber nossas notícias mais recentes por e-mail.